Antiphospholipid antibodies and cell activation: crucial role of p38 MAPK pathway

Khamashta MA. Hughes syndrome: history. In: Khamashta MA , ed. Hughes Syndrome: Antiphospholipid syndrome. London: Springer-Verlag , 2000: 3-7.

Atsumi T , Matsuura E , Koike T. Immunology of antiphospholipid antibodies and co-factors. In: Lahita RG , ed. Systemic lupus erythematosus. San Diego: Academic Press , 2004: 1081-1105.

Mann K. Biochemistry and physiology of blood coagulation . Thromb Haemost 1999; 82: 165-174 .

Mackman N. Regulation of the tissue factor gene . Faseb J 1995; 9: 883-889 .

Kornberg A , Blank M , Kaufman S , Shoenfeld Y. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies . J Immunol 1994; 153: 1328-1332 .

Atsumi T , Khamashta MA , Amengual O , Hughes GRV. Up-regulated tissue factor expression in antiphospholipid syndrome . Thromb Haemost 1997; 77: 222-223 .

Cuadrado MJ , Lopez-Pedreira C , Khamashta MA et al. Thrombosis in primary antiphospholipid syndrome. A pivotal role for monocyte tissue factor expression . Arthritis Rheum 1997; 40: 834-841 .

Amengual O , Atsumi T , Khamashta MA , Hughes GRV. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome . Thromb Haemost 1998; 79: 276-281 .

Khamashta MA , Harris EN , Gharavi AE et al. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes . Ann Rheum Dis 1988; 47: 849-854 .

Shechter Y , Tal Y , Greenberg A , Brenner B. Platelet activation in patients with antiphospholipid syndrome . Blood Coagul Fibrinolysis 1998; 9: 653-657 .

Hasselaar P , Derksen RH , Blokzijl L , de Groot PG. Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets . Thromb Haemost 1990; 63: 169-173 .

Zhou H , Wolberg AS , Roubey RA. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep . Blood 2004; 104: 2353-2358 .

Campbell AL , Pierangeli SS , Wellhausen S , Harris EN. Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation . Thromb Haemost 1995; 73: 529-534 .

Espinola RG , Pierangeli SS , Gharavi AE , Harris EN. Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies . Thromb Haemost 2002; 87: 518-522 .

Raschi E , Testoni C , Bosisio D et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies . Blood 2003; 101: 3495-3500 .

Zhang J , McCrae KR. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies . Blood 2005; 105: 1964-1969 .

Meroni PL , Raschi E , Testoni C et al. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype . Arthritis Rheum 2001; 44: 2870-2878 .

Dunoyer-Geindre S , De Moerloose P , Galve-De Rochemonteix B , Reber G , Kruithof E. NFkappaB is an essential intermediate in the activation of endothelial cells by anti-beta(2) glycoprotein 1 antibodies . Thromb Haemost 2002; 88: 851-857 .

Espinola RG , Liu X , Colden-Stanfield M , Hall J , Harris EN , Pierangeli SS. E-Selectin mediates pathogenic effects of antiphospholipid antibodies . J Thromb Haemost 2003; 1: 843-848 .

Ma K , Simantov R , Zhang JC , Silverstein R , Hajjar KA , McCrae KR. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II . J Biol Chem 2000; 275: 15541-15548 .

Lutters BC , Derksen RH , Tekelenburg WL , Lenting PJ , Arnout J , de Groot PG. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 20 . J Biol Chem 2003; 278: 33831-33838 .

McGilvray ID , Tsai V , Marshall JC , Dackiw AP , Rotstein OD. Monocyte adhesion and transmigration induce tissue factor expression: role of the mitogen-activated protein kinases . Shock 2002; 18: 51-57 .

Ohsawa M , Koyama T , Nara N , Hirosawa S. Induction of tissue factor expression in human monocytic cells by protease inhibitors through activating activator protein-1 (AP-1) with phosphorylation of Jun-N-terminal kinase and p38 . Thromb Res 2003; 112: 313-320 .

Blum S , Issbruker K , Willuweit A et al. An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression . J Biol Chem 2001; 276: 33428-33434 .

Eto M , Kozai T , Cosentino F , Joch H , Luscher TF. Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways . Circulation 2002; 105: 1756-1759 .

Ono K , Han J. The p38 signal transduction pathway: activation and function . Cell Signal 2000; 12: 1-13 .

Nakajima K , Tohyama Y , Kohsaka S , Kurihara T. Protein kinase C alpha requirement in the activation of p38 mitogen-activated protein kinase, which is linked to the induction of tumor necrosis factor alpha in lipopolysaccharide-stimulated microglia . Neurochem Int 2004; 44: 205-214 .

Vega-Ostertag M , Harris EN , Pierangeli SS. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin . Arthritis Rheum 2004; 50: 2911-2919 .

Bohgaki M , Atsumi T , Yamashita Y et al. The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies . Int Immunol 2004; 16: 1633-1641 .

Vega-Ostertag M , Casper K , Swerlick R , Ferrara D , Harris EN , Pierangeli SS. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies . Arthritis Rheum 2005; 52: 1545-1554 .